Allen Mark R
Known title: EVP GENL COUNSEL/SECTYCIK: 0001718431
Associated companies
Transaction History
| FDX | ▲ Buy | Option Exercise | 4,900 | $1.0M | 6/28/2024 | View on chart |
| FDX | ▲ Buy | Option Exercise | 12,360 | $2.7M | 6/28/2024 | View on chart |
| FDX | ▲ Buy | Option Exercise | 26,655 | $4.3M | 6/28/2024 | View on chart |
| FDX | ▲ Buy | Option Exercise | 29,015 | $3.8M | 6/28/2024 | View on chart |
| FDX | ▼ Sell | Open Market | 42,837 | $12.7M | 6/28/2024 | View on chart |
| FDX | ▼ Sell | Open Market | 33,041 | $9.8M | 6/28/2024 | View on chart |
| FDX | ▼ Sell | Open Market | 2,052 | $609K | 6/28/2024 | View on chart |
| FDX | ▲ Buy | Grant | 3,112 | $0 | 6/27/2024 | View on chart |
| FDX | ▼ Sell | Open Market | 10,145 | $2.9M | 3/28/2024 | View on chart |
| FDX | ▲ Buy | Option Exercise | 4,645 | $840K | 3/28/2024 | View on chart |
| FDX | ▲ Buy | Option Exercise | 5,500 | $896K | 3/28/2024 | View on chart |
| FDX | ▲ Buy | Grant | 3,959 | $0 | 6/22/2023 | View on chart |
| FDX | ▲ Buy | Grant | 4,005 | $0 | 6/30/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking
FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking. FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.